Cervarix Side Effects
Generic name: human papillomavirus vaccine
Medically reviewed by Drugs.com. Last updated on Jul 13, 2024.
Note: This document provides detailed information about Cervarix Side Effects associated with human papillomavirus vaccine. Some dosage forms listed on this page may not apply specifically to the brand name Cervarix.
Applies to human papillomavirus vaccine: intramuscular suspension.
Serious side effects of Cervarix
Along with its needed effects, human papillomavirus vaccine (the active ingredient contained in Cervarix) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking human papillomavirus vaccine:
More common
- fever
Less common
- black, tarry stools
- bleeding gums
- blood in urine or stools
- blurred vision
- body aches or pain
- chills
- constipation
- cough
- depressed mood
- difficulty with breathing
- dry mouth
- dry skin and hair
- ear congestion
- feeling cold
- flushed, dry skin
- fruit-like breath odor
- headache
- hoarseness or husky voice
- increased hunger
- increased thirst
- increased urination
- loss of consciousness
- loss of voice
- muscle cramps and stiffness
- nasal congestion
- nausea
- pinpoint red spots on skin
- runny nose
- slowed heartbeat
- sneezing
- sore throat
- stomachache
- sweating
- troubled breathing
- unexplained weight loss
- unusual bleeding or bruising
- unusual tiredness or weakness
- vomiting
Rare
- difficulty with swallowing
- dizziness
- fast heartbeat
- hives
- itching
- noisy breathing
- puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue
- shortness of breath
- skin rash
- tightness in the chest
- wheezing
Incidence not known
- anxiety
- back pain, sudden and severe
- back, leg, or stomach pains
- bloating
- chest pain
- convulsions (seizures)
- dark urine
- fainting
- general body swelling
- hives or welts
- hoarseness
- inability to move the arms and legs
- indigestion
- irritation
- joint pain, stiffness, or swelling
- loss of appetite
- loss of bladder control
- muscle spasm or jerking of all extremities
- muscle weakness, sudden and progressing
- nosebleeds
- pain in the stomach, side, or abdomen, possibly radiating to the back
- pain, redness, or swelling in the arm or leg
- pale skin
- paralysis
- rash
- redness of the skin
- shakiness and unsteady walk, unsteadiness, trembling, or other problems with muscle control or coordination
- sudden loss of consciousness
- sudden numbness and weakness in the arms and legs
- sudden shortness of breath or troubled breathing
- swelling of the eyelids, face, lips, hands, or feet
- swollen, painful, or tender lymph glands in the neck, armpit, or groin
- yellowing of the eyes or skin
Other side effects of Cervarix
Some side effects of human papillomavirus vaccine may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- red streaks on the skin, swelling, tenderness, pain, or itching at the injection site
Less common
- changes in skin coloring
- cloudy urine
- diarrhea
- difficulty with moving
- general feeling of discomfort or illness
- hair loss, thinning of hair
- muscle pain or stiffness
- pain in the joints
- sleeplessness
- toothache
- trouble with sleeping
- unable to sleep
For Healthcare Professionals
Applies to human papillomavirus vaccine: intramuscular suspension.
General
The most common adverse events were injection site reactions, fatigue, headache, and myalgia.[Ref]
Local
- Very common (10% or more): Injection site pain (91.9%), injection site swelling (49%), injection site erythema (48.4%)
- Common (1% to 10%): Injection site pruritus, injection site hematoma, injection site induration, injection site hemorrhage, injection site warmth, injection site mass, injection site reaction
- Postmarketing reports: Injection site cellulitis[Ref]
Other
- Very common (10% or more): Fatigue (54.6%), headache (53.4%), pyrexia (13%), fever of 99.5F or higher (12.9%)
- Common (1% to 10%): Chlamydia infection, malaise
- Uncommon (0.1% to 1%): Death
- Postmarketing reports: Asthenia, chills[Ref]
Deaths occurred during clinical trials which were generally assessed as not vaccine related: car accidents, suicides, acute lymphocytic leukemia, hypovolemic septic shock, airplane crash, cerebral hemorrhage, gunshot wound, stomach adenocarcinoma, pulmonary embolus/deep vein thrombosis, sepsis, pancreatic cancer, arrhythmia, pulmonary tuberculosis, hyperthyroidism, post-operative pulmonary embolism and acute renal failure, traumatic brain injury/cardiac arrest, systemic lupus erythematosus, cerebrovascular accident, breast cancer, nasopharyngeal cancer, autoimmune disease, infectious disease, homicide, and 1 unexplained sudden death 678 days following the last vaccine dose.[Ref]
Musculoskeletal
- Very common (10% or more): Myalgia (48.8%), arthralgia (20.7%)
- Common (1% to 10%): Back pain
- Postmarketing reports: Pain in extremity[Ref]
Gastrointestinal
- Common (1% to 10%): Nausea, diarrhea, vomiting, abdominal pain upper, toothache
- Rare (less than 0.1%): Appendicitis, gastroenteritis
- Postmarketing reports: Pancreatitis[Ref]
Respiratory
- Common (1% to 10%): Nasopharyngitis, oropharyngeal pain, influenza, cough, nasal congestion, upper respiratory tract infection, pharyngitis
- Rare (0.01% to 0.1%): Pneumonia, pulmonary embolism, asthma
- Very rare (less than 0.01%): Bronchospasm
- Frequency not reported: Asthmatic crisis
- Postmarketing reports: Pulmonary embolus[Ref]
Nervous system
- Common (1% to 10%): Dizziness, migraine
- Postmarketing reports: Acute disseminated encephalomyelitis, Guillain-Barre syndrome, motor neuron disease, paralysis, seizures, syncope (including syncope associated with tonic-clonic movements and other seizure-like activity) sometimes resulting in falling with injury, transverse myelitis[Ref]
Immunologic
- Common (1% to 10%): New medical conditions potentially indicative of systemic autoimmune disorders
- Postmarketing reports: Autoimmune diseases[Ref]
New medical conditions potentially indicative of systemic autoimmune disorders included: arthralgia/arthritis/arthropathy, autoimmune thyroiditis, celiac disease, diabetes mellitus insulin dependent, erythema nodosum, hyperthyroidism, hypothyroidism, inflammatory bowel disease, multiple sclerosis, nephritis, optic neuritis, pigmentation disorder, psoriasis, Raynaud's phenomenon, rheumatoid arthritis, scleroderma/morphea, Stevens-Johnson syndrome, systemic lupus erythematosus, uveitis, alopecia areata, ankylosing spondylitis, autoimmune thrombocytopenia, myocarditis, proteinuria, skin depigmentation, dermatomyositis, vasculitis, and vitiligo.[Ref]
Hypersensitivity
- Common (1% to 10%): Injection site hypersensitivity
- Frequency not reported: Allergy to vaccine
- Postmarketing reports: Hypersensitivity reactions (including anaphylactic/anaphylactoid reactions, bronchospasm, and urticaria)[Ref]
Hematologic
- Uncommon (0.1% to 1%): Lymphadenopathy
- Postmarketing reports: Autoimmune hemolytic anemia, idiopathic thrombocytopenic purpura[Ref]
Psychiatric
- Common (1% to 10%): Insomnia[Ref]
Genitourinary
- Common (1% to 10%): Dysmenorrhea, vaginal infection, urinary tract infection
- Rare (less than 0.1%): Pelvic inflammatory disease, pyelonephritis[Ref]
Dermatologic
- Common (1% to 10%): Rash, urticaria, itching/pruritus
- Postmarketing reports: Cellulitis, angioedema, erythema multiforme[Ref]
Cardiovascular
- Postmarketing reports: Deep vein thrombosis[Ref]
References
1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
2. (2006) "Product Information. Gardasil (human papillomavirus vaccine)." Merck & Co., Inc
3. Cerner Multum, Inc. "Australian Product Information."
4. (2009) "Product Information. Cervarix (human papillomavirus vaccine)." GlaxoSmithKline
5. (2016) "Product Information. Gardasil 9 (human papillomavirus vaccine)." Merck & Co., Inc
More about Cervarix (human papillomavirus vaccine)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: viral vaccines
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Cervarix side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.